Almac Diagnostics Expands Biomarker Discovery Service with XCel Array

The new chip, based on Affymetrix's GeneChip platform, is intended for use in studies where cross-disease compatibility is important, an attribute that Almac calls a "notable advantage" for its pharmaceutical customers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.